Legis Daily

Prescription Drug Price Reporting Act

USA116th CongressHR-5239| House 
| Updated: 11/22/2019
David P. Joyce

David P. Joyce

Republican Representative

Ohio

Cosponsors (1)
Anthony Gonzalez (Republican)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Prescription Drug Price Reporting Act This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance. HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 23, 2019

Latest Companion Bill Action

S 116-1664
Introduced in Senate
Nov 21, 2019
Introduced in House
Nov 21, 2019
Referred to the House Committee on Energy and Commerce.
Nov 22, 2019
Referred to the Subcommittee on Health.
  • May 23, 2019

    Latest Companion Bill Action

    S 116-1664
    Introduced in Senate


  • November 21, 2019
    Introduced in House


  • November 21, 2019
    Referred to the House Committee on Energy and Commerce.


  • November 22, 2019
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 116-1664: Prescription Drug Price Reporting Act
Business recordsFederal preemptionGovernment information and archivesHealth care costs and insuranceInflation and pricesPrescription drugsRetail and wholesale tradesState and local government operations

Prescription Drug Price Reporting Act

USA116th CongressHR-5239| House 
| Updated: 11/22/2019
Prescription Drug Price Reporting Act This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance. HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 23, 2019

Latest Companion Bill Action

S 116-1664
Introduced in Senate
Nov 21, 2019
Introduced in House
Nov 21, 2019
Referred to the House Committee on Energy and Commerce.
Nov 22, 2019
Referred to the Subcommittee on Health.
  • May 23, 2019

    Latest Companion Bill Action

    S 116-1664
    Introduced in Senate


  • November 21, 2019
    Introduced in House


  • November 21, 2019
    Referred to the House Committee on Energy and Commerce.


  • November 22, 2019
    Referred to the Subcommittee on Health.
David P. Joyce

David P. Joyce

Republican Representative

Ohio

Cosponsors (1)
Anthony Gonzalez (Republican)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 116-1664: Prescription Drug Price Reporting Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business recordsFederal preemptionGovernment information and archivesHealth care costs and insuranceInflation and pricesPrescription drugsRetail and wholesale tradesState and local government operations